Aurobindo Pharma receives USFDA approval
Aurobindo Pharma has received tentative approval from the USFDA to manufacture and market Famciclovir tablets in the strengths of 125mg, 250mg and 500mg.
Famciclovir tables is the generic version of Novartis Pharmaceuticals Corp's Famvir tablets and is indicated for the treatment of recurrent mucocutaneous herpes simplex infections in HIV-infected patients and suppression of recurrent genital herpes in immunocompetent patients. The product has a market size of approximately US$ 170 million for the twelve months ended September 2010 according to IMS.
The company made this announcement during the trading hours on, 31 January 2011.
Feb 03, 2011